Search for: "Anda Pharmaceuticals, Inc"
Results 301 - 320
of 607
Sort by Relevance
|
Sort by Date
21 Jun 2012, 6:52 pm
That’s what happened when we saw the June 23, 2011 approval letter for Lannett Holdings, Inc. [read post]
17 Jun 2012, 9:55 pm
., Unit III; Invagen Pharmaceuticals, Inc. [read post]
1 Jun 2012, 1:58 pm
Teva Sues Mylan Over Multiple Sclerosis Drug COPAXONE®ShareTweetTeva Pharmaceutical Industries Ltd. issued a press release last week discussing the abbreviated new drug application (ANDA) containing a Paragraph IV certification for COPAXONE® (glatiramer acetate injection), filed by Mylan Pharmaceuticals Inc. [read post]
25 May 2012, 11:32 am
Mylan Pharmaceuticals Inc., C.A. [read post]
23 May 2012, 9:22 pm
.; Lupin Pharmaceuticals Inc. [read post]
21 May 2012, 9:33 pm
Mylan Pharmaceuticals Inc. 1:12-cv-00523; filed April 26, 2012 in the District Court of Delaware Infringement of U.S. [read post]
15 May 2012, 1:00 am
Sunovion Pharmaceuticals, Inc., the Federal Circuit affirmed the district court’s determination that it could exercise jurisdiction over a declaratory judgment action brought by a subsequent ANDA filer. [read post]
10 May 2012, 9:00 am
Gorbec Pharmaceutical Services, Inc. [read post]
10 May 2012, 9:00 am
Gorbec Pharmaceutical Services, Inc. [read post]
9 May 2012, 8:57 pm
Mylan Pharmaceuticals Inc. [read post]
8 May 2012, 5:59 pm
Plaintiffs sued several generic drug manufacturers, including Morton Grove Pharmaceuticals, Inc. [read post]
7 May 2012, 10:51 am
Sandoz, Inc. [read post]
7 May 2012, 5:00 am
Mylan Pharmaceuticals, Inc., ___ F. [read post]
30 Apr 2012, 9:37 pm
Noonan -- The practice of "reverse payments" in ANDA litigation (where, typically, the branded drug manufacturer settles litigation brought under 35 U.S.C. [read post]
23 Apr 2012, 1:46 pm
Lilly alleges that Apotex seeks approval for ANDA and that the product infringes its patents. [read post]
20 Apr 2012, 10:36 am
Plaintiffs/Appellants AstraZeneca Pharmaceuticals LP, AstraZeneca AB, IPR Pharmaceuticals, Inc., and The Brigham and Women’s Hospital, Inc. [read post]
17 Apr 2012, 5:55 pm
” The Court says that its decision is consistent with the circumstances surrounding the aftermath of the Federal Circuit’s decision in Mylan Pharmaceuticals, Inc. v. [read post]
16 Apr 2012, 9:49 pm
Sunovion Pharmaceuticals Inc., the Federal Circuit affirmed a District Court's conclusion that it had subject-matter jurisdiction over a declaratory judgment action of a second ANDA filer, and as a result also affirmed the District Court's final judgment of non-infringement (based on a stipulation of the parties). [read post]
15 Apr 2012, 8:47 pm
• Defendants: Par Pharmaceutical Companies Inc.; Par Pharmaceutical Inc. [read post]
5 Apr 2012, 1:41 pm
Karst – It was yet another exciting day in the Hatch-Waxman world when news broke Wednesday morning that Teva Pharmaceuticals USA, Inc. [read post]
